$IRIX
IRIDEX CORP

2013 Q4 Form 10-K Financial Statement

#000156459014001025 Filed on March 27, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2013 2012 Q4
Revenue $10.60M $38.27M $9.230M
YoY Change 14.84% 13.04% 11.74%
Cost Of Revenue $5.450M $19.69M $4.890M
YoY Change 11.45% 12.41% 14.52%
Gross Profit $5.150M $18.59M $4.340M
YoY Change 18.66% 13.71% 8.77%
Gross Profit Margin 48.58% 48.56% 47.02%
Selling, General & Admin $3.710M $12.74M $3.740M
YoY Change -0.8% -0.62% 31.69%
% of Gross Profit 72.04% 68.54% 86.18%
Research & Development $880.0K $3.680M $1.090M
YoY Change -19.27% -16.17% 22.47%
% of Gross Profit 17.09% 19.8% 25.12%
Depreciation & Amortization $130.0K $490.0K $120.0K
YoY Change 8.33% 14.75% 33.33%
% of Gross Profit 2.52% 2.64% 2.76%
Operating Expenses $4.590M $15.95M $4.830M
YoY Change -4.97% -7.28% 29.49%
Operating Profit $560.0K $2.633M -$490.0K
YoY Change -214.29% -406.16% -288.46%
Interest Expense -$371.0K
YoY Change 76.67%
% of Operating Profit -14.09%
Other Income/Expense, Net -$170.0K -$370.0K -$20.00K
YoY Change 750.0% 76.19% -60.0%
Pretax Income $390.0K $2.262M $290.0K
YoY Change 34.48% -937.78% 38.1%
Income Tax -$30.00K $31.00K $30.00K
% Of Pretax Income -7.69% 1.37% 10.34%
Net Earnings $410.0K $2.231M $240.0K
YoY Change 70.83% 55.15% -31.43%
Net Earnings / Revenue 3.87% 5.83% 2.6%
Basic Earnings Per Share $0.24
Diluted Earnings Per Share $41.46K $0.22 $27.21K
COMMON SHARES
Basic Shares Outstanding 9.805M 9.245M
Diluted Shares Outstanding 10.10M

Balance Sheet

Concept 2013 Q4 2013 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.44M $13.44M $11.90M
YoY Change 12.94% 12.94% 24.74%
Cash & Equivalents $13.44M $13.44M $11.90M
Short-Term Investments
Other Short-Term Assets $580.0K $580.0K $1.640M
YoY Change -64.63% -64.63% 187.72%
Inventory $10.61M $10.61M $8.035M
Prepaid Expenses
Receivables $7.345M $7.350M $5.480M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.97M $31.97M $27.06M
YoY Change 18.17% 18.14% -8.31%
LONG-TERM ASSETS
Property, Plant & Equipment $543.0K $540.0K $483.0K
YoY Change 12.42% 12.5% 48.62%
Goodwill $533.0K $533.0K
YoY Change 0.0% 0.0%
Intangibles $328.0K $554.0K
YoY Change -40.79% -25.64%
Long-Term Investments
YoY Change
Other Assets $303.0K $300.0K $287.0K
YoY Change 5.57% 3.45% 44.22%
Total Long-Term Assets $1.707M $1.710M $1.857M
YoY Change -8.08% -7.57% -29.74%
TOTAL ASSETS
Total Short-Term Assets $31.97M $31.97M $27.06M
Total Long-Term Assets $1.707M $1.710M $1.857M
Total Assets $33.68M $33.68M $28.91M
YoY Change 16.48% 16.5% -10.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.278M $2.280M $2.105M
YoY Change 8.22% 8.06% 33.23%
Accrued Expenses $1.592M $3.950M $1.242M
YoY Change 28.18% 27.42% -35.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.362M $7.360M $6.367M
YoY Change 15.63% 15.54% -28.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $461.0K $460.0K $640.0K
YoY Change -27.97% -28.13% -20.99%
Total Long-Term Liabilities $461.0K $460.0K $640.0K
YoY Change -27.97% -28.13% -20.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.362M $7.360M $6.367M
Total Long-Term Liabilities $461.0K $460.0K $640.0K
Total Liabilities $7.823M $7.820M $7.007M
YoY Change 11.65% 11.55% -27.93%
SHAREHOLDERS EQUITY
Retained Earnings -$14.92M -$17.15M
YoY Change -13.01% -7.74%
Common Stock $40.78M $94.00K
YoY Change 43277.66% 2.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.85M $25.85M $21.91M
YoY Change
Total Liabilities & Shareholders Equity $33.68M $33.68M $28.91M
YoY Change 16.48% 16.5% -10.07%

Cashflow Statement

Concept 2013 Q4 2013 2012 Q4
OPERATING ACTIVITIES
Net Income $410.0K $2.231M $240.0K
YoY Change 70.83% 55.15% -31.43%
Depreciation, Depletion And Amortization $130.0K $490.0K $120.0K
YoY Change 8.33% 14.75% 33.33%
Cash From Operating Activities -$590.0K $767.0K $560.0K
YoY Change -205.36% -167.4% -56.25%
INVESTING ACTIVITIES
Capital Expenditures -$140.0K $380.0K -$80.00K
YoY Change 75.0% -3.55% -20.0%
Acquisitions
YoY Change
Other Investing Activities -$90.00K $130.0K -$90.00K
YoY Change 0.0% -96.98% 12.5%
Cash From Investing Activities -$240.0K -$763.0K -$170.0K
YoY Change 41.18% 5.68% -5.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $426.0K
YoY Change -84.97%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 190.0K 1.029M -2.250M
YoY Change -108.44% -143.05% 3650.0%
NET CHANGE
Cash From Operating Activities -590.0K 767.0K 560.0K
Cash From Investing Activities -240.0K -763.0K -170.0K
Cash From Financing Activities 190.0K 1.029M -2.250M
Net Change In Cash -640.0K 1.033M -1.860M
YoY Change -65.59% -124.31% -278.85%
FREE CASH FLOW
Cash From Operating Activities -$590.0K $767.0K $560.0K
Capital Expenditures -$140.0K $380.0K -$80.00K
Free Cash Flow -$450.0K $387.0K $640.0K
YoY Change -170.31% -125.26% -53.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
576000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13444000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7345000
CY2013Q4 us-gaap Inventory Net
InventoryNet
10605000
CY2012 us-gaap Cost Of Revenue
CostOfRevenue
17513000
CY2011 us-gaap Gross Profit
GrossProfit
16290000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
1934000
CY2013 us-gaap Revenues
Revenues
38273000
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2012Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
510000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
328000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
554000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
104000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40671000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38958000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14921000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
25854000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33677000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
207000
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2012Q4 us-gaap Inventory Net
InventoryNet
8035000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1129000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
31970000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
543000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5480000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11901000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
483000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
445000
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8958000
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8935000
CY2013Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
468000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2278000
CY2013Q4 us-gaap Assets
Assets
33677000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7362000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1592000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
303000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6367000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1891000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
287000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
22426000
CY2012 us-gaap Operating Expenses
OperatingExpenses
17206000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
2633000
CY2013 us-gaap Operating Expenses
OperatingExpenses
15954000
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
297000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8452971
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8452971
CY2013Q4 us-gaap Liabilities
Liabilities
7823000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2012Q4 us-gaap Liabilities
Liabilities
7007000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
461000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
640000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
5000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-722000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-278000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1004000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2105000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17152000
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
500000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
21905000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
500000
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1563000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1133000
CY2012Q4 us-gaap Goodwill
Goodwill
533000
CY2012Q4 us-gaap Assets
Assets
28912000
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1242000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28912000
CY2012Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
453000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
146000
CY2013Q4 us-gaap Goodwill
Goodwill
533000
CY2011Q1 us-gaap Stockholders Equity
StockholdersEquity
19427000
CY2011 us-gaap Revenues
Revenues
33159000
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3913000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9899483
CY2012 us-gaap Revenues
Revenues
33859000
CY2012 us-gaap Gross Profit
GrossProfit
16346000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9899483
CY2011 us-gaap Cost Of Revenue
CostOfRevenue
16869000
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1027000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
173000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
2231000
CY2011 us-gaap Operating Expenses
OperatingExpenses
14356000
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013Q2 dei Entity Public Float
EntityPublicFloat
54494721
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9993948
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2012Q4 us-gaap Assets Current
AssetsCurrent
27055000
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2013 us-gaap Insurance Recoveries
InsuranceRecoveries
473000
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-860000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
94000
CY2012Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
5000000
CY2013 us-gaap Cost Of Revenue
CostOfRevenue
19686000
CY2011 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
1274000
CY2012 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
800000
CY2011 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
800000
CY2013 us-gaap Interest And Debt Expense
InterestAndDebtExpense
371000
CY2012 us-gaap Interest And Debt Expense
InterestAndDebtExpense
210000
CY2011 us-gaap Interest And Debt Expense
InterestAndDebtExpense
296000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2262000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-270000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2438000
CY2013 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2231000
CY2012 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-170000
CY2011 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2141000
CY2012 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-264000
CY2011 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
469000
CY2012 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
1872000
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1608000
CY2011 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
469000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
1438000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
2610000
CY2013 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.24
CY2012 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2011 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.24
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.18
CY2011 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.05
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2013 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.22
CY2012 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2011 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.21
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.18
CY2011 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.05
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9245000
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8935000
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10104000
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10225000
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
35000
CY2011 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
170000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
35000
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
170000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2231000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1473000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2780000
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
321000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
544000
CY2011 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
2000
CY2011 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
648000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
396000
CY2012 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
734000
CY2012 irix Adjustments To Additional Paid In Capital Stock Repurchased From Tender Offer Value
AdjustmentsToAdditionalPaidInCapitalStockRepurchasedFromTenderOfferValue
2101000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1495000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
689000
CY2012 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
5362000
CY2011 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
796000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1543000
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
648000
CY2013 irix Payment Of Legal Costs In Connection With Tender Offer
PaymentOfLegalCostsInConnectionWithTenderOffer
40000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1029000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2390000
CY2013 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
426000
CY2013 irix Adjustments To Additional Paid In Capital Stock Repurchased From Tender Offer Value
AdjustmentsToAdditionalPaidInCapitalStockRepurchasedFromTenderOfferValue
40000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
490000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
427000
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
410000
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
355000
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
215000
CY2011 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
280000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
689000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
388000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
478000
CY2011 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
-2000
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
61000
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
33000
CY2011 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-12000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1926000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-38000
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
82000
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2514000
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1376000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-553000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
665000
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
75000
CY2013 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
16000
CY2012 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
88000
CY2011 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-7000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
525000
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
66000
CY2013 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
328000
CY2012 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
383000
CY2011 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-209000
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
171000
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-756000
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
285000
CY2013 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
15000
CY2012 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-103000
CY2011 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-51000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
129000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-10000
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
12000
CY2013 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
28000
CY2012 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
21000
CY2011 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
26000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
767000
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1138000
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2251000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
380000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
394000
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
203000
CY2011 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
75000
CY2013 irix Payment On Earn Out Liability
PaymentOnEarnOutLiability
383000
CY2012 irix Payment On Earn Out Liability
PaymentOnEarnOutLiability
328000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-763000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1495000
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
445000
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
321000
CY2013 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
426000
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2835000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-327000
CY2012 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
695000
CY2011 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
797000
CY2013 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
510000
CY2012 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
4632000
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Discontinued Operations
EffectOfExchangeRateOnCashAndCashEquivalentsDiscontinuedOperations
35000
CY2011 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Discontinued Operations
EffectOfExchangeRateOnCashAndCashEquivalentsDiscontinuedOperations
-1000
CY2013 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
510000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1112000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2442000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10789000
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8347000
CY2013 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-536000
CY2012 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-145000
CY2011 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
522000
CY2011 us-gaap Interest Paid
InterestPaid
1000
CY2011 irix Contingent Consideration Earn Out Liability
ContingentConsiderationEarnOutLiability
105000
CY2013 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
5000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
58000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
52000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
86000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
16000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
16000
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
100000
CY2013Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
524000
CY2012Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
173000
CY2012 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
1131000
CY2013 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications. </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In February 2012, we completed the sale of our aesthetics business to Cutera</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Inc. In accordance with accounting principles generally accepted in the U.S. (&#8220;GAAP&#8221;), we have recast our financial information to show the results from our ophthalmology business as continuing operations and the results from our aesthetics business as discontinued operations. </font></p></div>
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on our operating results. </font></p></div>
CY2013 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Deferred Revenue. </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue related to service contracts is deferred and recognized on a straight line basis over the period of the applicable service period. Costs associated with these service arrangements are recognized as incurred. A reconciliation of the changes in the Company&#8217;s deferred revenue balances for the years ended December&#160;28, 2013 and December&#160;29, 2012 are as follows (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:68%;"> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="width:58%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FY 2011: Balance, December&#160;31, 2011</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:8%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,014</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="width:58%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions to deferral</font></p></td> <td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td> <td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="width:8%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,131</font></p></td> <td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="width:58%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue recognized</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,141</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td> </tr> <tr> <td valign="bottom" style="width:58%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FY 2012: Balance, December&#160;29, 2012</font></p></td> <td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td> <td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="width:8%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,004</font></p></td> <td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="width:58%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions to deferral</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:8%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,383</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="width:58%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue recognized</font></p></td> <td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td> <td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,254</font></p></td> <td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="width:58%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FY 2013: Balance, December&#160;28, 2013</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,133</font></p></td> <td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> </tr> </table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div>
CY2013Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
200000
CY2013Q4 irix Number Of Independent Distributors
NumberOfIndependentDistributors
70
CY2013Q4 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
100
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1630000
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10840000
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-325000
CY2011 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
653000
CY2013 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
CY2012 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
1149000
CY2013 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
CY2012 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
824000
CY2011 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
653000
CY2013 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
CY2012 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
-784000
CY2011 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
184000
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1014000
CY2012 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
1141000
CY2013 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
1383000
CY2013 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
1254000
CY2012Q4 irix Provision For Sales Returns
ProvisionForSalesReturns
53000
CY2013Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
1600000
CY2012Q4 irix Other Inventory Loaners
OtherInventoryLoaners
1400000
CY2011Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
556000
CY2012 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
173000
CY2012 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-276000
CY2013 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
213000
CY2013 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-198000
CY2013Q4 irix Provision For Sales Returns
ProvisionForSalesReturns
33000
CY2013Q4 irix Accumulated Amortization On Inventory Demo
AccumulatedAmortizationOnInventoryDemo
601000
CY2012Q4 irix Accumulated Amortization On Inventory Loaners
AccumulatedAmortizationOnInventoryLoaners
603000
CY2013 irix Estimated Useful Life Of Demos And Loaners
EstimatedUsefulLifeOfDemosAndLoaners
P4Y
CY2013 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2013 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
300000
CY2012 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
300000
CY2011 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
300000
CY2013 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2012 us-gaap Advertising Expense
AdvertisingExpense
200000
CY2011 us-gaap Advertising Expense
AdvertisingExpense
300000
CY2013 irix Entity Wide Revenue Number Of Major Customer
EntityWideRevenueNumberOfMajorCustomer
0
CY2012 irix Entity Wide Revenue Number Of Major Customer
EntityWideRevenueNumberOfMajorCustomer
0
CY2011 irix Entity Wide Revenue Number Of Major Customer
EntityWideRevenueNumberOfMajorCustomer
0
CY2013Q4 irix Entity Wide Account Receivables Number Of Major Customer
EntityWideAccountReceivablesNumberOfMajorCustomer
0
CY2012Q4 irix Entity Wide Account Receivables Number Of Major Customer
EntityWideAccountReceivablesNumberOfMajorCustomer
0
CY2013 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.10
CY2012 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.10
CY2011 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.10
CY2013 irix Entity Wide Receivable Major Customer Percentage
EntityWideReceivableMajorCustomerPercentage
0.10
CY2012 irix Entity Wide Receivable Major Customer Percentage
EntityWideReceivableMajorCustomerPercentage
0.10
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
510000
CY2012 irix Percentage Of Purchase Price To Be Deposited In Escrow Account
PercentageOfPurchasePriceToBeDepositedInEscrowAccount
0.10
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
765000
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
328000
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
652000
CY2013 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
383000
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
624000
CY2013Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
6898000
CY2012Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
5357000
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3707000
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2678000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8821000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8557000
CY2013 us-gaap Depreciation
Depreciation
264000
CY2012 us-gaap Depreciation
Depreciation
236000
CY2011 us-gaap Depreciation
Depreciation
185000
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2012 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2011 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
226000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
960000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
632000
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
328000
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
191000
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
960000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
406000
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
554000
CY2012Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
158000
CY2013Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
184000
CY2012Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
156000
CY2012Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
49000
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
32000
CY2012Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
32000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
541000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
674000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
866000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
226000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
92000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
14000
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
111000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1198000
CY2013Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1178000
CY2013Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
750000
CY2013Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
750000
CY2013Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
375000
CY2013Q4 us-gaap Contractual Obligation
ContractualObligation
3053000
CY2013 irix Operating Lease Additional Lease Period
OperatingLeaseAdditionalLeasePeriod
P6Y
CY2013 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
600000
CY2012 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
600000
CY2011 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
600000
CY2013 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
750000
CY2013 irix Amount Of Purchases Made Under Agreement
AmountOfPurchasesMadeUnderAgreement
134000
CY2013 us-gaap Long Term Purchase Commitment Description
LongTermPurchaseCommitmentDescription
The agreement, which terminates on July 2017, is renewable at the end of the term for successive one year terms.
CY2013Q4 irix Percentage Of Royalty Paid On Net Sales
PercentageOfRoyaltyPaidOnNetSales
0.05
CY2013 us-gaap Royalty Expense
RoyaltyExpense
100000
CY2012 us-gaap Royalty Expense
RoyaltyExpense
100000
CY2011 us-gaap Royalty Expense
RoyaltyExpense
200000
CY2013 irix Early Termination Year Of License Agreement
EarlyTerminationYearOfLicenseAgreement
2018
CY2013 irix Late Termination Year Of License Agreement
LateTerminationYearOfLicenseAgreement
2021
CY2007Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
500000
CY2007Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
760137
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantAdditionalSharesReserved
163378
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod
319900
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
100315
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantExercisedInPeriod
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod
72274
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantExpired
70353
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
505221
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantAdditionalSharesReserved
391166
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod
335050
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
66665
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantExercisedInPeriod
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod
356277
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantExpired
108971
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
741978
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantAdditionalSharesReserved
52128
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantsInPeriod
149600
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
234012
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantExercisedInPeriod
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeituresInPeriod
123679
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantExpired
57628
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
476545
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1618066
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Options Number Of Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNumberOfAdditionalSharesReserved
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
319900
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
99291
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
72274
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1766401
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Options Number Of Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNumberOfAdditionalSharesReserved
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
335050
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
174631
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6287000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1042611
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
356277
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1570543
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Options Number Of Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNumberOfAdditionalSharesReserved
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
149600
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
493622
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
123679
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1102842
CY2011Q1 irix Share Based Compensation Arrangement By Share Based Payment Award Outstanding Options Aggregate Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingOptionsAggregateValue
5906000
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Options Additional Shares Reserved Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalSharesReservedIntrinsicValue
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.16
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.60
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.47
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
689000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
388000
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
478000
CY2012 irix Allocated Share Based Compensation Expense Discontinued Operations
AllocatedShareBasedCompensationExpenseDiscontinuedOperations
8000
CY2011 irix Allocated Share Based Compensation Expense Discontinued Operations
AllocatedShareBasedCompensationExpenseDiscontinuedOperations
66000
CY2013 irix Share Based Compensation Expense Including Discontinued Operations
ShareBasedCompensationExpenseIncludingDiscontinuedOperations
689000
CY2012 irix Share Based Compensation Expense Including Discontinued Operations
ShareBasedCompensationExpenseIncludingDiscontinuedOperations
396000
CY2011 irix Share Based Compensation Expense Including Discontinued Operations
ShareBasedCompensationExpenseIncludingDiscontinuedOperations
544000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M13D
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
1148000
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Aggregate Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalAggregatePrice
-321000
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue
353000
CY2011 irix Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue
CY2011Q4 irix Share Based Compensation Arrangement By Share Based Payment Award Outstanding Options Aggregate Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingOptionsAggregateValue
6380000
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Options Additional Shares Reserved Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalSharesReservedIntrinsicValue
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
1313000
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Aggregate Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalAggregatePrice
-445000
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue
1550000
CY2012 irix Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue
CY2012Q4 irix Share Based Compensation Arrangement By Share Based Payment Award Outstanding Options Aggregate Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingOptionsAggregateValue
5698000
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Options Additional Shares Reserved Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalSharesReservedIntrinsicValue
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
851000
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Aggregate Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalAggregatePrice
-1495000
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue
698000
CY2013 irix Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue
CY2013Q4 irix Share Based Compensation Arrangement By Share Based Payment Award Outstanding Options Aggregate Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingOptionsAggregateValue
4356000
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.65
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.59
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.24
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.88
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.61
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.92
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.55
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.35
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.63
CY2013 irix Share Based Compensation Arrangements By Share Based Payment Award Options Additional Shares Reserved In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdditionalSharesReservedInPeriodWeightedAverageExercisePrice
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.69
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.03
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.64
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.97
CY2013Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1579387
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0112
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0068
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0098
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M18D
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y8M12D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.715
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.892
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.922
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1500000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
261000
CY2007Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
600000
CY2011 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.038
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.023
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.93
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y5M23D
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5981000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
701524
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.69
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y3M29D
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4196000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
84000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1400000
CY2013 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M21D
CY2007Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.01
CY2007Q3 irix Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
2007-12-31
CY2007Q3 irix Number Of Warrants Used To Calculate Per Share Purchase Price Of Stock And Warrants
NumberOfWarrantsUsedToCalculatePerSharePurchasePriceOfStockAndWarrants
1.2
CY2007Q3 irix Purchase Price Of Preferred Stock And Warrants
PurchasePriceOfPreferredStockAndWarrants
10.00
CY2007Q3 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2300000
CY2013Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1000000
CY2013 irix Defined Contribution Plan Employee Contribution Percentage
DefinedContributionPlanEmployeeContributionPercentage
0.15
CY2012 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.50
CY2013 irix Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
170000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2262000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-270000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2438000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
11000
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-114000
CY2011 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
267000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
20000
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
14000
CY2011 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
30000
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2011 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
31000
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-100000
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
297000
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2011 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2011 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.133
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.881
CY2011 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
-0.020
CY2013 irix Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.170
CY2012 irix Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.891
CY2011 irix Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.000
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.000
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.000
CY2013Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
441000
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1.803
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.158
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.014
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.371
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.124
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1792000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2295000
CY2013Q4 irix Deferred Tax Assets Deferred Revenue
DeferredTaxAssetsDeferredRevenue
91000
CY2012Q4 irix Deferred Tax Assets Deferred Revenue
DeferredTaxAssetsDeferredRevenue
38000
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
423000
CY2012Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
429000
CY2012Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
180000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
696000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
753000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5224000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5310000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1260000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1008000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
47000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
47000
CY2012Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-1000
CY2013Q4 irix Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
9974000
CY2012Q4 irix Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
10061000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9974000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10061000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
954000
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1191000
CY2011Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
865000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
48000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
36000
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
58000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
25000
CY2011 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
268000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
273000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1027000
CY2013Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
67000
CY2013Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2013Q4 irix Unrecognized Tax Benefits In Which No Material Changes Anticipated
UnrecognizedTaxBenefitsInWhichNoMaterialChangesAnticipated
1000000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
87000
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1600000
CY2011 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
414000
CY2013 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2013 irix Number Of Customers Accounted For More Than Ten Percent Of Revenue
NumberOfCustomersAccountedForMoreThanTenPercentOfRevenue
0
CY2012 irix Number Of Customers Accounted For More Than Ten Percent Of Revenue
NumberOfCustomersAccountedForMoreThanTenPercentOfRevenue
0
CY2011 irix Number Of Customers Accounted For More Than Ten Percent Of Revenue
NumberOfCustomersAccountedForMoreThanTenPercentOfRevenue
0
CY2013 irix Individual Country Accounted
IndividualCountryAccounted
1
CY2012 irix Individual Country Accounted
IndividualCountryAccounted
1
CY2011 irix Individual Country Accounted
IndividualCountryAccounted
1
CY2013 irix Share As Percentage To Sales
ShareAsPercentageToSales
0.550
CY2012 irix Share As Percentage To Sales
ShareAsPercentageToSales
0.546
CY2011 irix Share As Percentage To Sales
ShareAsPercentageToSales
0.556
CY2013 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
448000
CY2011 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1000000
CY2013 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
291000
CY2011 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
245000
CY2013 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
120000
CY2011 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
22000
CY2012 irix Stock Options To Purchase Shares Excluded From Computation Of Diluted Weighted Average Shares Outstanding
StockOptionsToPurchaseSharesExcludedFromComputationOfDilutedWeightedAverageSharesOutstanding
1570543
CY2012 irix Common Stock Equivalents From Conversion Of Preferred Excluded From Computation Of Diluted Weighted Average Shares Outstanding
CommonStockEquivalentsFromConversionOfPreferredExcludedFromComputationOfDilutedWeightedAverageSharesOutstanding
1000000

Files In Submission

Name View Source Status
0001564590-14-001025-index-headers.html Edgar Link pending
0001564590-14-001025-index.html Edgar Link pending
0001564590-14-001025.txt Edgar Link pending
0001564590-14-001025-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
irix-10k_20131228.htm Edgar Link pending
irix-20131228.xml Edgar Link completed
irix-20131228.xsd Edgar Link pending
irix-20131228_cal.xml Edgar Link unprocessable
irix-20131228_def.xml Edgar Link unprocessable
irix-20131228_lab.xml Edgar Link unprocessable
irix-20131228_pre.xml Edgar Link unprocessable
irix-ex23_20131228256.htm Edgar Link pending
irix-ex31_20131228257.htm Edgar Link pending
irix-ex31_20131228258.htm Edgar Link pending
irix-ex32_20131228259.htm Edgar Link pending
irix-ex32_20131228260.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending